Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1369-1379

  Schnyder, Bruno ^a   Lugli, Serena M ^a   Schnyder Candrian, Silvia ^b   Eng, Vicki M ^a   Moser, René ^a   Banchereau, Jacques ^c   Ryffel, Bernhard ^a   Car, Bruce D ^a,d  

^a SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c MERCK RESEARCH LABORATORIES   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; CROSS LINKING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MARMOSET; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CALLITHRIX; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENISTEIN; HUMANS; ISOFLAVONES; LYMPHOCYTES; MUSCLE, SMOOTH; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0029846902     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Banchereau J, Rybak ME: Interleukin-4. Cytokine Handbook. Edited by AW Thomson. London, Academic Press, 1994, pp 99-126
2. H2 response and in immunoglobulin E production. Science 1995, 270:1845-1847
3. Moser R, Fehr J, Bruijnzeel PL: IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992, 149:1432-1438
4. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone M Jr, McIntyre BW, Bochner BS: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992, 148:1086-1092
5. Herbert J-M, Savi P, Laplace M-C, Lale A, Dol F, Dumas A, Labit C, Minty A: IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 1993, 328:268-270
6. Tepper RI, Coffman RL, Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4, Science 1992, 257:548-551
7. Lahm H, Schnyder B, Wyniger J, Borbenyi Z, Yilmaz A, Car BD, Fischer JR, Givel JC, Ryffel B: Growth inhibition of human colorectal carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int J Cancer 1994, 59:440-447
8. Derocq J-M, Segui M, Poinot-Chazel C, Minty A, Caput D, Ferrara P, Casellas P: Interleukin-13 stimulates interleukin-6 production by human keratinocytes: similarity with interleukin-4. FEBS (Fed Eur Biochem Soc) Lett 1994, 343:32-36
9. Koettnitz K, Kalthoff FS: Human interleukin-4 receptor signaling requires sequences contained within two cytoplasmic regions. Eur J Immunol 1993, 23:988-991
10. Kuhne MR, Zhizhuan Z, Rowles J, Lavan BE, Shen S-H, Fischer EH, Lienhard GE: Dephosphorylation of insulin receptor substrate 1 by the tyrosine phophatase PTP2C. J Biol Chem 1994, 269:15833-15837
11. Keegan KD, Nelms K, Wang L-M, Pierce JH, Paul WE: An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994, 76:811-820
12. Foxwell BM, Woerly G, Ryffel B: Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells. Eur J Immunol 1989, 19:1637-1641
13. Galizzi JP, Castle B, Djossou O, Harada N, Cabrillat H, Yahia SA, Barrett R, Howard M, Banchereau J: Purification of a 130-kDa T cell glycoprotein that binds human interleukin 4 with high affinity. J Biol Chem 1990, 265:439-444
14. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996, 93:497-501
15. Callard RE, Matthews DJ, Hibbert L: IL-4 and IL-13 receptors: are they one and the same? Immunol Today 1996, 17:108-110
16. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993, 12:2663-2670
17. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie ANJ, Miossec P, Bancherau J, Zurawski J: The primary binding site of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995, 270:13869-13878
18. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, Leonard WJ: Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 1993, 262:1880-1883
19. Schnyder-Candrian S, Strieter RM, Kunkel SL, Walz A: Interferon-α and interferon-γ downregulate the production of interleukin-8 and ENA-78 in human monocytes. J Leukocyte Biol 1995, 57:929-935
20. Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Loems Ziegler-Heitbrock HW, Siess W, Weber PC: Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 1995, 155:445-451
21. Ishii N, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, Sugamura K: Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int Immunol 1994, 6:1273-1276
22. Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK: Expression of high affinity interleukin-4 receptors on human renal carcinoma cells and inhibition of tumour cell growth in vitro by IL-4. J Clin Invest 1993, 91:88-93
23. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157
24. Giri JG, Ahdieh M, Eisenmann J, Shaneback K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994, 13:2822-2830
25. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475
26. Feng NP, Schnyder B, Vonderschmitt DJ, Ryffel B, Lutz RA: Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor. J Rec Signal Trans Res 1995, 15:931-949
27. Enright WJ, Booth P: Specificity of inhibitors of tyrosine kinases. Focus 1991, 13:79-82
28. Zurawski G, DeFries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells but not on T cells. Immunol Today 1994, 15:19-26
29. Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F, Zurawski SM, Zurawski G, deVries JE: An interleukin-4 (IL-4) mutant protein inhibits both IL-4 and IL-13-induced human immunoglobulin G4 (IgG4) and lgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993, 178:2213-2218
30. Moser R, Fehr J, Olgiati L, Bruijnzeel PL: Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 1992, 79:2937-2945
31. 3 gene. J Biol Chem 1995, 270: 4115-4120
32. 3 for angiogenesis. Science 1994, 264:569-571
33. Creamer D, Allen M, Sousa A, Poston R, Barker J: Altered vascular endothelium integrin expression in psoriasis. Am J Pathol 1995, 147:1661-1667
34. He Y-W, Malek TR: The IL-2 receptor γc-chain does not function as a subunit shared by the IL-4 and IL-13 receptors: implication for the structure of the IL-4 receptor. J Immunol 1995, 155:9-12
35. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250
36. Bergese SD, Huang EH, Pelletier RP, Widmer MB, Ferguson RM, Orosz CG: Regulation of endothelial VCAM-1 expression in murine cardiac grafts: expression of allograft endothelial VCAM-1 can be manipulated with antagonist of TNF-α or IL-4 and is not required for allograft rejection. Am J Pathol 1995, 147: 166-175
37. Schnyder B, Lahm H, Woerly G, Odartchenko N, Ryffel B, Car BD: Growth inhibition signalled through the IL-13/IL-4 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate. Biochem. J 1996, 315:767-774
38. + T cell infiltration. J Immunol 1992, 149:2954-2960
39. Moser R: Transendothelial migration of eosinophils: unanswered questions. Ann NY Acad Sci 1994, 725:156-162
40. Moser R, Groscurth P, Carbadillo JM, Bruijnzeel PLB, Blaser K, Heusser CH, Fehr J: Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med 1993, 122:567-575
41. Palmer-Crocker RL, Pober JS: IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J Immunol 1995, 154:2838-2845